{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:06:44Z","timestamp":1790770004555,"version":"4.1.0"},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T00:00:00Z","timestamp":1450828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0144787","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T13:58:57Z","timestamp":1450879137000},"page":"e0144787","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":105,"title":["Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors"],"prefix":"10.1371","volume":"10","author":[{"given":"Hannah","family":"Karlsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Gigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Jarvius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Olsson-Str\u00f6mberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Savoldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpietro","family":"Dotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Loskog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,12,23]]},"reference":[{"issue":"177","key":"ref1","doi-asserted-by":"crossref","first-page":"177ra38","DOI":"10.1126\/scitranslmed.3005930","article-title":"CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia","volume":"5","author":"RJ Brentjens","year":"2013","journal-title":"Sci Transl Med"},{"issue":"95","key":"ref2","doi-asserted-by":"crossref","first-page":"95ra73","DOI":"10.1126\/scitranslmed.3002842","article-title":"T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia","volume":"3","author":"M Kalos","year":"2011","journal-title":"Sci Transl Med"},{"issue":"16","key":"ref3","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia","volume":"368","author":"SA Grupp","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1200\/JCO.2014.56.2025","article-title":"Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor","volume":"33","author":"JN Kochenderfer","year":"2015","journal-title":"J Clin Oncol"},{"issue":"224","key":"ref5","doi-asserted-by":"crossref","first-page":"224ra25","DOI":"10.1126\/scitranslmed.3008226","article-title":"Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia","volume":"6","author":"ML Davila","year":"2014","journal-title":"Sci Transl Med"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1073\/pnas.90.2.720","article-title":"Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors","volume":"90","author":"Z Eshhar","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"ref7","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1158\/1078-0432.CCR-06-1183","article-title":"A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer","volume":"12","author":"MH Kershaw","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"13","key":"ref8","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1200\/JCO.2006.05.9964","article-title":"Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience","volume":"24","author":"CH Lamers","year":"2006","journal-title":"J Clin Oncol"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1182\/blood-2007-12-128843","article-title":"Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells","volume":"112","author":"BG Till","year":"2008","journal-title":"Blood"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1038\/sj.leu.2404366","article-title":"Addition of the CD28 signaling domain to chimeric T-cell receptors enhances chimeric T-cell resistance to T regulatory cells","volume":"20","author":"A Loskog","year":"2006","journal-title":"Leukemia"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1172\/JCI46110","article-title":"CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients","volume":"121","author":"B Savoldo","year":"2011","journal-title":"J Clin Invest"},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1089\/hum.2007.028","article-title":"Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains","volume":"18","author":"J Wang","year":"2007","journal-title":"Hum Gene Ther"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nbt0102-70","article-title":"Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta \/CD28 receptor","volume":"20","author":"J Maher","year":"2002","journal-title":"Nat Biotechnol"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4049\/jimmunol.172.1.104","article-title":"Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain","volume":"172","author":"HM Finney","year":"2004","journal-title":"J Immunol"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1182\/blood-2006-04-017061","article-title":"T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells","volume":"108","author":"J Vera","year":"2006","journal-title":"Blood"},{"issue":"22","key":"ref16","doi-asserted-by":"crossref","first-page":"10995","DOI":"10.1158\/0008-5472.CAN-06-0160","article-title":"CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells","volume":"66","author":"CM Kowolik","year":"2006","journal-title":"Cancer Res"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/sj.leu.2403302","article-title":"Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia","volume":"18","author":"C Imai","year":"2004","journal-title":"Leukemia"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/hum.2009.122","article-title":"4-1BB and CD28 signaling plays a synergistic role in redirecting umbilical cord blood T cells against B-cell malignancies","volume":"21","author":"S Tammana","year":"2010","journal-title":"Hum Gene Ther"},{"issue":"9","key":"ref19","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1073\/pnas.0813101106","article-title":"Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains","volume":"106","author":"C Carpenito","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ymthe.2005.04.016","article-title":"A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells","volume":"12","author":"MA Pule","year":"2005","journal-title":"Mol Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2407-14-30","article-title":"Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice","volume":"14","author":"V Hillerdal","year":"2014","journal-title":"BMC Cancer"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/2326-6066.CIR-14-0192","article-title":"T cells bearing a chimeric antigen receptor against prostate-specific membrane antigen mediate vascular disruption and result in tumor regression","volume":"3","author":"SP Santoro","year":"2015","journal-title":"Cancer immunology research"},{"issue":"12","key":"ref23","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1089\/hum.2013.209","article-title":"A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancer","volume":"25","author":"D Abate-Daga","year":"2014","journal-title":"Hum Gene Ther"},{"issue":"24","key":"ref24","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1158\/1078-0432.CCR-14-1170","article-title":"Development of T cells redirected to glypican-3 for the treatment of hepatocellular carcinoma","volume":"20","author":"H Gao","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1158\/1078-0432.CCR-13-0709","article-title":"EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss","volume":"20","author":"JH Sampson","year":"2014","journal-title":"Clinical Cancer Research"},{"issue":"17","key":"ref26","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1182\/blood-2011-10-387969","article-title":"CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results","volume":"119","author":"BG Till","year":"2012","journal-title":"Blood"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/mt.2009.83","article-title":"Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo","volume":"17","author":"MC Milone","year":"2009","journal-title":"Mol Ther"},{"key":"ref28","article-title":"CD19-targeted chimeric antigen receptor T cell therapy for acute lymphoblastic leukemia","author":"SL Maude","year":"2015","journal-title":"Blood"},{"issue":"16","key":"ref29","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"SL Maude","year":"2014","journal-title":"N Engl J Med"},{"issue":"9967","key":"ref30","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(14)61403-3","article-title":"T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial","volume":"385","author":"DW Lee","year":"2015","journal-title":"Lancet"},{"issue":"7","key":"ref31","first-page":"1300","article-title":"Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines","volume":"28","author":"E Klein","year":"1968","journal-title":"Cancer Res"},{"issue":"16\u201317","key":"ref32","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0161-5890(97)00144-2","article-title":"Construction and characterisation of a functional CD19 specific single chain Fv fragment for immunotherapy of B lineage leukaemia and lymphoma","volume":"34","author":"IC Nicholson","year":"1997","journal-title":"Mol Immunol"},{"issue":"24","key":"ref33","doi-asserted-by":"crossref","first-page":"9709","DOI":"10.1073\/pnas.85.24.9709","article-title":"Molecular cloning and chromosomal localization of the human T-cell receptor zeta chain: distinction from the molecular CD3 complex","volume":"85","author":"AM Weissman","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"ref34","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1073\/pnas.92.15.6733","article-title":"Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells","volume":"92","author":"I Riviere","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/joim.12020","article-title":"Genetically engineered T cells for the treatment of cancer","volume":"273","author":"M Essand","year":"2013","journal-title":"J Intern Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.immunol.021908.132706","article-title":"T cell activation","volume":"27","author":"JE Smith-Garvin","year":"2009","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nri1148","article-title":"Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?","volume":"3","author":"M Croft","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/mt.2009.210","article-title":"Chimeric antigen receptors combining 4-1BB and CD28 signaling domains augment PI3kinase\/AKT\/Bcl-XL activation and CD8+ T cell-mediated tumor eradication","volume":"18","author":"XS Zhong","year":"2010","journal-title":"Mol Ther"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/hum.2012.247","article-title":"Adoptive immunotherapy with redirected T cells produces CCR7- cells that are trapped in the periphery and benefit from combined CD28-OX40 costimulation","volume":"24","author":"AA Hombach","year":"2013","journal-title":"Hum Gene Ther"},{"issue":"11","key":"ref40","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.1882","article-title":"Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma","volume":"14","author":"MA Pule","year":"2008","journal-title":"Nature medicine"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1182\/blood-2011-03-344275","article-title":"CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo","volume":"119","author":"DG Song","year":"2012","journal-title":"Blood"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1172\/JCI32103","article-title":"Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates","volume":"118","author":"C Berger","year":"2008","journal-title":"J Clin Invest"},{"issue":"41","key":"ref43","doi-asserted-by":"crossref","first-page":"17469","DOI":"10.1073\/pnas.0907448106","article-title":"Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity","volume":"106","author":"CS Hinrichs","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"ref44","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.2446","article-title":"A human memory T cell subset with stem cell-like properties","volume":"17","author":"L Gattinoni","year":"2011","journal-title":"Nature medicine"},{"issue":"24","key":"ref45","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1182\/blood-2014-01-552174","article-title":"Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15","volume":"123","author":"Y Xu","year":"2014","journal-title":"Blood"},{"issue":"5","key":"ref46","doi-asserted-by":"crossref","first-page":"e64138","DOI":"10.1371\/journal.pone.0064138","article-title":"Manufacture of clinical-grade CD19-specific T cells stably expressing chimeric antigen receptor using Sleeping Beauty system and artificial antigen presenting cells","volume":"8","author":"H Singh","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jcyt.2013.10.013","article-title":"Relation of clinical culture method to T-cell memory status and efficacy in xenograft models of adoptive immunotherapy","volume":"16","author":"DM Barrett","year":"2014","journal-title":"Cytotherapy"},{"key":"ref48","article-title":"The non-signaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor activity","author":"M Hudecek","year":"2014","journal-title":"Cancer immunology research"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1600-065X.2008.00756.x","article-title":"Calmodulin-dependent phosphatase, kinases, and transcriptional corepressors involved in T-cell activation","volume":"228","author":"JO Liu","year":"2009","journal-title":"Immunol Rev"},{"issue":"6","key":"ref50","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nrm1661","article-title":"Annexins: linking Ca2+ signalling to membrane dynamics","volume":"6","author":"V Gerke","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"ref51","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.bbamcr.2008.01.030","article-title":"Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization","volume":"1783","author":"HO van Genderen","year":"2008","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nri2470","article-title":"'Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation","volume":"9","author":"D Perretti M","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"ref53","doi-asserted-by":"crossref","first-page":"e62449","DOI":"10.1371\/journal.pone.0062449","article-title":"Annexin A1 on the surface of early apoptotic cells suppresses CD8+ T cell immunity","volume":"8","author":"H Weyd","year":"2013","journal-title":"PLoS One"},{"issue":"Pt 1","key":"ref54","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/bj3100243","article-title":"In vivo and in vitro phosphorylation of annexin II in T cells: potential regulation by annexin V","volume":"310","author":"T Dubois","year":"1995","journal-title":"Biochem J"},{"issue":"12","key":"ref55","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.4049\/jimmunol.1202313","article-title":"Cyclin-dependent kinase 2 controls peripheral immune tolerance","volume":"189","author":"N Chunder","year":"2012","journal-title":"J Immunol"},{"issue":"34","key":"ref56","doi-asserted-by":"crossref","first-page":"24494","DOI":"10.1074\/jbc.M113.467704","article-title":"Foxp3 protein stability is regulated by cyclin-dependent kinase 2","volume":"288","author":"PA Morawski","year":"2013","journal-title":"J Biol Chem"},{"issue":"1","key":"ref57","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cellimm.2014.05.004","article-title":"Inhibition of CDK2 promotes inducible regulatory T-cell differentiation through TGFbeta-Smad3 signaling pathway","volume":"290","author":"H Gu","year":"2014","journal-title":"Cell Immunol"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4049\/jimmunol.1200868","article-title":"Early growth response gene-2 controls IL-17 expression and Th17 differentiation by negatively regulating Batf","volume":"190","author":"T Miao","year":"2013","journal-title":"J Immunol"},{"issue":"1","key":"ref59","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/ncb2395","article-title":"The adaptor protein CRK is a pro-apoptotic transducer of endoplasmic reticulum stress","volume":"14","author":"K Austgen","year":"2012","journal-title":"Nat Cell Biol"},{"issue":"24","key":"ref60","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1182\/blood-2008-10-182329","article-title":"Cytoskeletal protein 4.1R negatively regulates T-cell activation by inhibiting the phosphorylation of LAT","volume":"113","author":"Q Kang","year":"2009","journal-title":"Blood"},{"issue":"12","key":"ref61","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.4049\/jimmunol.1301587","article-title":"Focal adhesion kinase negatively regulates Lck function downstream of the T cell antigen receptor","volume":"191","author":"NM Chapman","year":"2013","journal-title":"J Immunol"},{"issue":"3","key":"ref62","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/cvr\/cvr023","article-title":"Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo","volume":"90","author":"C Grebe","year":"2011","journal-title":"Cardiovasc Res"},{"issue":"7093","key":"ref63","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature04631","article-title":"A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT","volume":"441","author":"Y Gwack","year":"2006","journal-title":"Nature"},{"issue":"1","key":"ref64","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4049\/jimmunol.1100178","article-title":"A role for p120 RasGAP in thymocyte positive selection and survival of naive T cells","volume":"187","author":"PE Lapinski","year":"2011","journal-title":"J Immunol"},{"issue":"11","key":"ref65","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.4049\/jimmunol.1003690","article-title":"Paxillin associates with the microtubule cytoskeleton and the immunological synapse of CTL through its leucine-aspartic acid domains and contributes to microtubule organizing center reorientation","volume":"187","author":"LK Robertson","year":"2011","journal-title":"J Immunol"},{"issue":"2","key":"ref66","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.molimm.2013.12.002","article-title":"The adaptor protein SAP directly associates with PECAM-1 and regulates PECAM-1-mediated-cell adhesion in T-like cell lines","volume":"58","author":"R Proust","year":"2014","journal-title":"Mol Immunol"},{"issue":"2","key":"ref67","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.immuni.2012.09.023","article-title":"Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor","volume":"38","author":"DM Zaiss","year":"2013","journal-title":"Immunity"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0144787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T22:27:39Z","timestamp":1540333659000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0144787"}},"subtitle":[],"editor":[{"given":"Kjetil","family":"Tasken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,23]]},"references-count":67,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0144787","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,23]]}}}